Project Grant R21DA060422
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $265,239 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of North Carolina at Chapel Hill (UNC-CH) to investigate the effects of vaping-induced oxidation on nicotine analogs in e-cigarettes. The project aims to evaluate the chemical composition of 6-methyl nicotine and nicotinamide vaping products before and after aerosolization, and assess...
- This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) is providing $931,766 to West Virginia University to evaluate dependence and nicotine replacement therapy-supported cessation efforts among regular electronic cigarette (e-cigarette) users. The project aims to assess unique indicators of e-cigarette dependence in individuals who have never been established cigarette smokers or have transitioned from cigarette smoking to...
- The National Institute on Drug Abuse (NIDA) awarded Evidation Health, Inc. a $608,046 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a digital product called RESHAPE. The objective of this project is to create a digital platform that addresses the health-related social needs (HRSN) impacting substance use disorder (SUD) recovery. Evidation will conduct formative research, develop, and deploy a new digital experience called RESHAPE to improve...
- This $723,676 federal Project Grant award was provided by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to Wake Forest University Health Sciences (WFUHS) to conduct research on the long-term effects of electronic cigarettes on brain health. The research project aims to investigate the comparative impacts of smoking cessation versus switching from traditional cigarettes to e-cigarettes on measures such as gray matter volume, white matter...
- This $693,491 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a mixed methods study to advance the scientific understanding of nicotine pouch use among U.S. adults. The study will employ a nationally representative longitudinal survey integrated with qualitative interviews to investigate who is using nicotine pouches, their reasons for use, methods, frequency, and intensity of use, as well as...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $639,920 project grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Board of Regents of the Nevada System of Higher Education, operating through the University of Nevada, Reno. The grant, which runs from September 15, 2025 to May 31, 2030, will fund a human laboratory study to examine the influence of "natural" cigarillo descriptors on expectancies, subjective...
- The federal Project Grant award of $353,508 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research conducted by Clemson University to evaluate the use of electronic cigarettes (ECs) as a harm reduction strategy for people with opioid use disorder (OUD) on buprenorphine treatment. The grant will fund a 5-year career development and research plan that aims to prepare the principal investigator to become an independent clinical...
- This $105,076 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the neurocomputational basis of effort-based decision making (EBDM) in individuals with tobacco use disorder, tobacco and opioid use disorder, and healthy controls. The award will support research to characterize the neurocomputational basis of EBDM during a smoking cessation attempt. The project will computationally model...
- This federal Project Grant award of $437,250.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund a nationwide, longitudinal survey of 430 teen-parent dyads where the teen has a history of substance use and the parent uses digital location tracking (DLT) apps to monitor their teen. The study aims to characterize how and why parents use DLT, as well...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $823,882 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Oregon Health & Science University (OHSU) on July 15, 2025. The TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care project aims to implement and compare two outreach strategies, a person-based Outreach Navigator (ON) and a technology-based Interactive Patient Portal (IPP), to improve...
The National Institute on Drug Abuse (NIDA) awarded a $254,810 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Research Foundation for the State University of New York (RF SUNY). The grant's goal is to validate the use of a wrist-worn Fitbit device to accurately measure and assess e-cigarette use behaviors in real-time among young adults. The project will examine the validity of the e-cigarette use data collected by the Fitbit device compared to video-recorded and self-reported data. This research aims to contribute to a comprehensive understanding of young people's e-cigarette use patterns and support the development of effective just-in-time interventions for e-cigarette cessation. The award period is from January 1, 2025, to December 31, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $254.8k | 12/16/24 |